Concepedia

Patrick Archdeacon

PA

17

Publications

1.4K

Citations

16

H-Index

1994

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Clinical Research Institute

Harvard University

Duke University

Patrick Archdeacon is an author at Center for Drug Evaluation and Research specializing in medicine, patient safety, and nephrology.

Top concepts

MedicineNephrologyPatient SafetyHealth PolicyChronic Kidney DiseaseDrug SafetyPublic HealthPharmacotherapyUrologyHemodialysis

Publications per year

1994–2018

17

Publications

17

Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the α subunit

Myles H. Akabas, Christine Kaufmann, Patrick Archdeacon et al. · Neuron · 1994 · 428 citations

Entire M2 Segment, α Subunit, Molecular Physiology +11

Summary of FDA Antibody-Mediated Rejection Workshop

Patrick Archdeacon, Marieta Chan, Carolyn Y. Neuland et al. · American Journal of Transplantation · 2011 · 174 citations · Full text

Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator.

Myles H. Akabas, Christine Kaufmann, Tiffany Cook et al. · Journal of Biological Chemistry · 1994 · 147 citations · Full text

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

Colin Baigent, William G. Herrington, Josef Coresh et al. · Kidney International · 2017 · 145 citations · Full text

Summary of the US FDA Approval of Belatacept

Patrick Archdeacon, Caitlin Dixon, Ozlem Belen et al. · American Journal of Transplantation · 2012 · 108 citations · Full text

Organ Donation, Solid Organ Transplantation, Pharmacotherapy +16

Rows per page

1–5 of 17